LINC02351

Across TCGA pan-cancer cohorts, LINC02351 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated LINC02351 data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher LINC02351 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC02351 expression acts as an unfavorable survival marker, although some lineages such as HNSC and DLBC show a favorable association.

LIHC, HNSC, and THCA are the cancer types where LINC02351 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Tertile	All	0.605	0.813	<.001	99	view →
HNSC	DFS	Quartile	III,IV	0.776	0.619	.003	47	view →
THCA	OS	Tertile	All	0.973	0.996	.001	39	view →
BRCA	DFS	Tertile	All	0.570	1.000	.033	36	view →
DLBC	DFS	Tertile	All	0.938	0.314	.004	29	view →
THYM	OS	Median	II,III,IV	0.698	1.000	.001	24	view →
UCEC	OS	Quartile	III,IV	0.709	0.841	.021	20	view →
READ	DFS	Quartile	III,IV	0.396	0.814	.005	15	view →
KIRP	OS	Tertile	All	0.488	0.827	.015	14	view →
KICH	DFS	Tertile	III,IV	0.043	0.897	.045	9	view →
LUSC	DFS	Tertile	All	0.314	0.458	.020	9	view →
MESO	OS	Quartile	IV	0.935	0.437	.016	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

LINC02351–LIHC (OS)

Open the LIHC breakdown →